Myriad Genetics base_AAQS 2025
Myriad Genetics base_AAQS
2
components_StockPageHeader__3
MYGN
components_StockPageHeader__4
US62855J1043
components_StockPageHeader__5
897518
pages_kennzahlen_[key]_[isin]__35
Myriad Genetics Aktienanalyse
pages_kennzahlen_[key]_[isin]__1
Myriad Genetics Inc. is a biotechnology company specializing in the research of cancer and genetic analysis technologies. The company was founded in 1991 by Mark Skolnick and has since become a global leader in personalized medicine and diagnostics. It is headquartered in Salt Lake City, Utah, USA, and employs over 2,400 employees worldwide. Myriad Genetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.pages_dividenden_[isin]_index__2
components_kpi_Savingsplan_0
Andere Kennzahlen von Myriad Genetics
components_SimilarSitesList_0
- Myriad Genetics base_Umsatz
- Myriad Genetics base_Gewinn
- Myriad Genetics base_KGV
- Myriad Genetics base_KUV
- Myriad Genetics base_EBIT
- Myriad Genetics base_Dividende
- Myriad Genetics base_Aktien
- Myriad Genetics base_Marktkapitalisierung
- Myriad Genetics base_Schulden
- Myriad Genetics base_Verbindlichkeiten
- Myriad Genetics base_Eigenkapital
- Myriad Genetics base_AAQS
- Myriad Genetics base_Mitarbeiter
- Myriad Genetics base_ROE
- Myriad Genetics base_ROA
- Myriad Genetics base_ROCE
